# Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma

> **NCT00808899** · PHASE2 · TERMINATED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 4 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** Temsirolimus
- **DRUG:** Irinotecan
- **PROCEDURE:** Surgical Resection of Primary Tumor
- **DRUG:** Cyclophosphamide
- **DRUG:** Doxorubicin
- **DRUG:** Etoposide
- **DRUG:** Cisplatin
- **DRUG:** Topotecan
- **PROCEDURE:** PBSC
- **RADIATION:** Radiation Therapy
- **DRUG:** 13-cis-retinoic acid

## Key facts

- **NCT ID:** NCT00808899
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Voluntarily closed and terminated by the PI due to lack of feasibility
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00808899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00808899, "Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00808899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*